284 related articles for article (PubMed ID: 18505426)
21. [Expression of FOXP3 in CD4+ CD39+ T cells of patients with systemic lupus erythematosus and dynamic observation of treatment with glucocorticoid].
Li DM; Li XP; Li XM; Wang GS; Ma Y; Zhao SS; Zheng SG
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(23):1636-8. PubMed ID: 19957514
[TBL] [Abstract][Full Text] [Related]
22. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH
Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
[TBL] [Abstract][Full Text] [Related]
23. Analysis of FOXP3
Schmidt A; Rieger CC; Venigalla RK; Éliás S; Max R; Lorenz HM; Gröne HJ; Krammer PH; Kuhn A
Immunol Res; 2017 Apr; 65(2):551-563. PubMed ID: 28224362
[TBL] [Abstract][Full Text] [Related]
24. Quantification of regulatory T cells in peripheral blood of patients with systemic lupus erythematosus.
Habibagahi M; Habibagahi Z; Jaberipour M; Aghdashi A
Rheumatol Int; 2011 Sep; 31(9):1219-25. PubMed ID: 20361330
[TBL] [Abstract][Full Text] [Related]
25. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients.
Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S
Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042
[TBL] [Abstract][Full Text] [Related]
26. Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells?
Yang HX; Zhang W; Zhao LD; Li Y; Zhang FC; Tang FL; He W; Zhang X
Arthritis Res Ther; 2009; 11(5):R153. PubMed ID: 19821980
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus.
Bonelli M; Savitskaya A; Steiner CW; Rath E; Smolen JS; Scheinecker C
J Immunol; 2009 Feb; 182(3):1689-95. PubMed ID: 19155519
[TBL] [Abstract][Full Text] [Related]
28. Regulatory T cells and their molecular markers in peripheral blood of the patients with systemic lupus erythematosus.
Hu S; Xiao W; Kong F; Ke D; Qin R; Su M
J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):549-52. PubMed ID: 18846336
[TBL] [Abstract][Full Text] [Related]
29. Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids.
Suárez A; López P; Gómez J; Gutiérrez C
Ann Rheum Dis; 2006 Nov; 65(11):1512-7. PubMed ID: 16606650
[TBL] [Abstract][Full Text] [Related]
30. Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus.
Lyssuk EY; Torgashina AV; Soloviev SK; Nassonov EL; Bykovskaia SN
Adv Exp Med Biol; 2007; 601():113-9. PubMed ID: 17712998
[TBL] [Abstract][Full Text] [Related]
31. T-regs in autoimmune hepatitis-systemic lupus erythematosus/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile.
Longhi MS; Ma Y; Grant CR; Samyn M; Gordon P; Mieli-Vergani G; Vergani D
J Autoimmun; 2013 Mar; 41():146-51. PubMed ID: 23287048
[TBL] [Abstract][Full Text] [Related]
32. CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids.
Azab NA; Bassyouni IH; Emad Y; Abd El-Wahab GA; Hamdy G; Mashahit MA
Clin Immunol; 2008 May; 127(2):151-7. PubMed ID: 18299252
[TBL] [Abstract][Full Text] [Related]
33. Two separate effects contribute to regulatory T cell defect in systemic lupus erythematosus patients and their unaffected relatives.
Costa N; Marques O; Godinho SI; Carvalho C; Leal B; Figueiredo AM; Vasconcelos C; Marinho A; Moraes-Fontes MF; Gomes da Costa A; Ponte C; Campanilho-Marques R; Cóias T; Martins AR; Viana JF; Lima M; Martins B; Fesel C
Clin Exp Immunol; 2017 Sep; 189(3):318-330. PubMed ID: 28542701
[TBL] [Abstract][Full Text] [Related]
34. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.
Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL
Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064
[TBL] [Abstract][Full Text] [Related]
35. CD4
Silva-Neta HL; Brelaz-de-Castro MCA; Chagas MBO; Mariz HA; de Arruda RG; de Vasconcelos VF; Pereira MC; Romano A; Pitta IR; Marques CDL; Duarte ALBP; Rêgo MJBM; Pitta MGR
Biomed Res Int; 2018; 2018():3419565. PubMed ID: 30009168
[TBL] [Abstract][Full Text] [Related]
36. Identity of mysterious CD4+CD25-Foxp3+ cells in SLE.
Horwitz DA
Arthritis Res Ther; 2010; 12(1):101. PubMed ID: 20122288
[TBL] [Abstract][Full Text] [Related]
37. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus.
Valencia X; Yarboro C; Illei G; Lipsky PE
J Immunol; 2007 Feb; 178(4):2579-88. PubMed ID: 17277168
[TBL] [Abstract][Full Text] [Related]
38. [Study of fas-mediated Foxp3+CD4+CD25+ Treg cell apoptosis in patients with systemic lupus erythematosus].
Lin XJ; Luo M; Cai XY
Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(9):586-90. PubMed ID: 21600126
[TBL] [Abstract][Full Text] [Related]
39. Increased CD45RA+ FoxP3(low) regulatory T cells with impaired suppressive function in patients with systemic lupus erythematosus.
Pan X; Yuan X; Zheng Y; Wang W; Shan J; Lin F; Jiang G; Yang YH; Wang D; Xu D; Shen L
PLoS One; 2012; 7(4):e34662. PubMed ID: 22506043
[TBL] [Abstract][Full Text] [Related]
40. Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus.
Barath S; Aleksza M; Tarr T; Sipka S; Szegedi G; Kiss E
Lupus; 2007; 16(7):489-96. PubMed ID: 17670847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
